Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Zarontin — ZARONTIN
Application NDA012380 (NDA)
Camoquin Hydrochloride — CAMOQUIN HYDROCHLORIDE
Application NDA006441 (NDA)
Vira-A — VIRA-A
Application NDA050523 (NDA)
Vira-A — VIRA-A
Application NDA050486 (NDA)
Benadryl — BENADRYL
Application NDA005845 (NDA)
Benadryl — BENADRYL
Application NDA006146 (NDA)
Benadryl — BENADRYL PRESERVATIVE FREE
Application NDA009486 (NDA)
Benadryl — BENYLIN
Application NDA006514 (NDA)
Povan — POVAN
Application NDA011964 (NDA)
Povan — POVAN
Application NDA012485 (NDA)
Coly-Mycin M — COLY-MYCIN S
Application NDA050355 (NDA)
Theelin — THEELIN
Application NDA003977 (NDA)
Meclomen — MECLOMEN
Application NDA018006 (NDA)
Nardil — NARDIL
Application NDA011909 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)